What to watch with CYP2C19 and fertility?

The provided context contains no direct evidence linking CYP2C19 to fertility. CYP2C19 is a drug-metabolizing enzyme primarily involved in processing medications such as proton pump inhibitors, certain antidepressants (e.g., citalopram), and clomiphene. Some studies suggest a possible role of CYP2C19 variants in hormone metabolism or outcomes of fertility treatments, but the evidence is weak and not sufficient for clinical recommendations. Direct-to-consumer tests that claim a strong link to fertility are overstating the science. Key factors for fertility include age, hormonal status, lifestyle, and medically supervised diagnostics. If you are taking medications metabolized by CYP2C19, genetic variants may affect dosing – this should be discussed with a physician or pharmacist. Evidence grade: unclear.